![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 5
Zeitschriftenartikel
Gosewisch, Astrid; Delker, Andreas; Tattenberg, Sebastian; Ilhan, Harun; Todica, Andrei; Brosch, Julia; Vomacka, Lena; Brunegraf, Anika; Gildehaus, Franz Josef; Ziegler, Sibylle; Bartenstein, Peter und Boening, Guido
(2018):
Patient-specific image-based bone marrow dosimetry in Lu-177-[DOTA(0),Tyr(3)]-Octreotate and Lu-177-DKFZ-PSMA-617 therapy: investigation of a new hybrid image approach.
In: EJNMMI Research, Bd. 8, 76
[PDF, 2MB]
Vomacka, Lena; Albert, Nathalie L. 
ORCID: https://orcid.org/0000-0003-0953-7624; Lindner, Simon; Unterrainer, Marcus; Mahler, Christoph; Brendel, Matthias; Ermoschkin, Larissa; Gosewisch, Astrid; Brunegraf, Anika; Buckley, Christopher; Kümpfel, Tania; Rupprecht, Rainer; Ziegler, Sibylle; Kerschensteiner, Martin; Bartenstein, Peter und Böning, Guido
(2017):
TSPO imaging using the novel PET ligand [F-18]GE-180: quantification approaches in patients with multiple sclerosis.
In: EJNMMI Research, Bd. 7, 89
[PDF, 2MB]
ORCID: https://orcid.org/0000-0003-0953-7624; Lindner, Simon; Unterrainer, Marcus; Mahler, Christoph; Brendel, Matthias; Ermoschkin, Larissa; Gosewisch, Astrid; Brunegraf, Anika; Buckley, Christopher; Kümpfel, Tania; Rupprecht, Rainer; Ziegler, Sibylle; Kerschensteiner, Martin; Bartenstein, Peter und Böning, Guido
(2017):
TSPO imaging using the novel PET ligand [F-18]GE-180: quantification approaches in patients with multiple sclerosis.
In: EJNMMI Research, Bd. 7, 89
[PDF, 2MB]
Unterrainer, Marcus; Fleischmann, Daniel; Lindner, Simon; Brunegraf, Anika; Vettermann, Franziska; Vomacka, Lena; Brendel, Matthias; Rupprecht, Rainer; Belka, Claus; Bartenstein, Peter; Niyazi, Maximilian und Albert, Nathalie L. ORCID: https://orcid.org/0000-0003-0953-7624
(2017):
TSPO-PET for glioma imaging using the novel ligand [F-18]GE-180-first in human results in high-grade glioma patients.
In: Journal of Nuclear Medicine, Bd. 58
ORCID: https://orcid.org/0000-0003-0953-7624
(2017):
TSPO-PET for glioma imaging using the novel ligand [F-18]GE-180-first in human results in high-grade glioma patients.
In: Journal of Nuclear Medicine, Bd. 58
Vomacka, Lena; Albert, Nathalie L. ORCID: https://orcid.org/0000-0003-0953-7624; Lindner, Simon; Unterrainer, Marcus; Mahler, Christoph; Brendel, Matthias; Ermoschkin, Larissa; Gosewisch, Astrid; Brunegraf, Anika; Kmpfel, Tania; Kerschensteiner, Martin; Bartenstein, Peter und Böning, Guido
(2017):
Quantification of the new TSPO ligand [F-18]GE-180 in patients with multiple sclerosis - initial results.
In: Journal of Nuclear Medicine, Bd. 58
ORCID: https://orcid.org/0000-0003-0953-7624; Lindner, Simon; Unterrainer, Marcus; Mahler, Christoph; Brendel, Matthias; Ermoschkin, Larissa; Gosewisch, Astrid; Brunegraf, Anika; Kmpfel, Tania; Kerschensteiner, Martin; Bartenstein, Peter und Böning, Guido
(2017):
Quantification of the new TSPO ligand [F-18]GE-180 in patients with multiple sclerosis - initial results.
In: Journal of Nuclear Medicine, Bd. 58
Delker, Andreas; Fendler, Wolfgang Peter; Kratochwil, Clemens; Brunegraf, Anika; Gosewisch, Astrid; Gildehaus, Franz Josef; Tritschler, Stefan; Stief, Christian Georg; Kopka, Klaus; Haberkorn, Uwe; Bartenstein, Peter und Böning, Guido
(2016):
Dosimetry for ¹⁷⁷Lu-DKFZ-PSMA-617: a new radiopharmaceutical for the treatment of metastatic prostate cancer.
In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 43, Nr. 1: S. 42-51